Investing Profile

Larry Lasky

InvestorVC

Partner at The Column Group

Photo of Larry Lasky, Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
The Column Group Partner
$100K - $5.0M
$1.5M
6
CompanyStageDateRound SizeTotal Raised
Eikon Therapeutics
Series AMay 2021$148M
$148M
Co-investors: Adam Goulburn (Lux Capital)
Accent Therapeutics
Series AMay 2018$40M
$40M
Co-investors: Jason Rhodes (Atlas Venture)
Revolution Medicines
Series ADec 2016$25M
$81M
Co-investors: Thilo Schroeder (Nextech Invest)
Cleave Therapeutics
Series ANov 2011$42M
$90M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Robert Garland (New Enterprise Associates (NEA)), Peter Thompson (OrbiMed), Marc Singer (Osage University Partners), Andrew Schwab (5am Ventures), Kush Parmar (5am Ventures), Alfred Scheidegger (Nextech Invest)
Calithera Biosciences
Series AJul 2010$40M
$81M
Co-investors: Jean George (Lightstone VC), Christoph Westphal (Longwood Fund)
OncoMed Pharmaceuticals
Series BNov 2008$154M
$154M